Caseware UK (AP4) 2023.0.135 2023.0.135 2024-03-312024-03-312023-04-01falsefalseNo description of principal activity44truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 03961404 2023-04-01 2024-03-31 03961404 2022-04-01 2023-03-31 03961404 2024-03-31 03961404 2023-03-31 03961404 2022-04-01 03961404 1 2023-04-01 2024-03-31 03961404 d:Director2 2023-04-01 2024-03-31 03961404 d:Director5 2023-04-01 2024-03-31 03961404 e:FurnitureFittings 2023-04-01 2024-03-31 03961404 e:FurnitureFittings 2024-03-31 03961404 e:FurnitureFittings 2023-03-31 03961404 e:FurnitureFittings e:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 03961404 e:LeaseholdInvestmentProperty 2024-03-31 03961404 e:LeaseholdInvestmentProperty 2023-03-31 03961404 e:LeaseholdInvestmentProperty 4 2023-04-01 2024-03-31 03961404 e:CurrentFinancialInstruments 2024-03-31 03961404 e:CurrentFinancialInstruments 2023-03-31 03961404 e:CurrentFinancialInstruments e:WithinOneYear 2024-03-31 03961404 e:CurrentFinancialInstruments e:WithinOneYear 2023-03-31 03961404 e:ShareCapital 2024-03-31 03961404 e:ShareCapital 2023-03-31 03961404 e:ShareCapital 2022-04-01 03961404 e:RetainedEarningsAccumulatedLosses 2023-04-01 2024-03-31 03961404 e:RetainedEarningsAccumulatedLosses 2024-03-31 03961404 e:RetainedEarningsAccumulatedLosses 1 2023-04-01 2024-03-31 03961404 e:RetainedEarningsAccumulatedLosses 2022-04-01 2023-03-31 03961404 e:RetainedEarningsAccumulatedLosses 2023-03-31 03961404 e:RetainedEarningsAccumulatedLosses 2022-04-01 03961404 d:OrdinaryShareClass1 2023-04-01 2024-03-31 03961404 d:OrdinaryShareClass1 2024-03-31 03961404 d:OrdinaryShareClass1 2023-03-31 03961404 d:FRS102 2023-04-01 2024-03-31 03961404 d:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 03961404 d:FullAccounts 2023-04-01 2024-03-31 03961404 d:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 03961404 e:MoreThanFiveYears 2024-03-31 03961404 e:MoreThanFiveYears 2023-03-31 03961404 e:AcceleratedTaxDepreciationDeferredTax 2024-03-31 03961404 e:AcceleratedTaxDepreciationDeferredTax 2023-03-31 03961404 6 2023-04-01 2024-03-31 03961404 f:PoundSterling 2023-04-01 2024-03-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 03961404










THE BUNGAY MEDICAL CENTRE PROPERTY COMPANY LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2024

 
THE BUNGAY MEDICAL CENTRE PROPERTY COMPANY LIMITED
REGISTERED NUMBER: 03961404

STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
-
136,376

Investments
 5 
-
418,534

Investment property
 6 
-
2,160,000

  
-
2,714,910

Current assets
  

Debtors: amounts falling due within one year
 7 
1
8,994

Cash at bank and in hand
 8 
-
49,275

  
1
58,269

Creditors: amounts falling due within one year
 9 
-
(33,539)

Net current assets
  
 
 
1
 
 
24,730

Total assets less current liabilities
  
1
2,739,640

Provisions for liabilities
  

Deferred tax
 10 
-
(41,209)

  
 
 
-
 
 
(41,209)

Net assets
  
1
2,698,431


Capital and reserves
  

Called up share capital 
 11 
1
20,000

Profit and loss account
  
-
2,678,431

  
1
2,698,431


Page 1

 
THE BUNGAY MEDICAL CENTRE PROPERTY COMPANY LIMITED
REGISTERED NUMBER: 03961404
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 MARCH 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the income statement in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Professor C H Hand
I R Huggins
Director
Director


Date: 2 September 2024

The notes on pages 4 to 10 form part of these financial statements.

Page 2

 
THE BUNGAY MEDICAL CENTRE PROPERTY COMPANY LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2024


Called up share capital
Profit and loss account
Total equity

£
£
£


At 1 April 2022
20,000
2,665,803
2,685,803


Comprehensive income for the year

Profit for the year
-
202,233
202,233

Gift aid payment to parent charity
-
(189,605)
(189,605)



At 1 April 2023
20,000
2,678,431
2,698,431


Comprehensive income for the year

Profit for the year
-
201,822
201,822

Gift of net assets to parent charity (note 1.2)
-
(2,548,682)
(2,548,682)

Capital reduction
(19,999)
19,999
-

Gift aid payment to parent charity
-
(351,570)
(351,570)


At 31 March 2024
1
-
1


The notes on pages 4 to 10 form part of these financial statements.

Page 3

 
THE BUNGAY MEDICAL CENTRE PROPERTY COMPANY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1.Accounting policies

 
1.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are presented in sterling which is the functional currency of the Company and rounded to the nearest £.

The following principal accounting policies have been applied:

 
1.2

Going concern

On the 31 March 2024 the Company merged with its newly incorporated parent charity, The Bungay Medical Centre CIO (known as The Bungay Medical Centre Charitable Trust / Scott Charity prior to incorporation). It achieved this by transferring by way of gift, all assets, liabilities and operations to The Bungay Medical Centre CIO. The net carrying value of the gift was £2,548,682. The gift is reflected in the Statement of Changes in Equity. 
From 31 March 2024, the Company Limited has been dormant, and following the completion of the transfer, the Directors intend to remove the Company from the register held by the Companies House once final administrative matters have been dealt with.
As a result the financial statements are prepared on a basis other than going concern, which includes, where appropriate, writing down assets to net realisable value, and recognising any contractual commitments that have become onerous at the balance sheet date. No material adjustments arose as a result of ceasing to apply the going concern basis. The financial statements do not include any provision for the future costs of winding-up the company, except to the extent that such costs were committed at the balance sheet date.

  
1.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Rental income from investment property leased out under operating leases is recognised in the statement of comprehensive income on a straight-line basis over the length of the lease. 

Page 4

 
THE BUNGAY MEDICAL CENTRE PROPERTY COMPANY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1.Accounting policies (continued)

 
1.4

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

 
1.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Fixtures & fittings
-
7.5% on a straightline basis

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 5

 
THE BUNGAY MEDICAL CENTRE PROPERTY COMPANY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1.Accounting policies (continued)

 
1.6

Investment property

Investment property is carried at fair value determined annually by external valuers and derived from the current market rents and investment property yields for comparable real estate, adjusted if necessary for any difference in the nature, location or condition of the specific asset. No depreciation is provided. Changes in fair value are recognised in profit or loss.

 
1.7

Valuation of investments

Investments in listed company shares are remeasured to market value at each reporting date. Gains and losses on remeasurement are recognised in profit or loss for the period.

  
1.8

Gift Aid payments

Gift Aid payments to the parent charity are recognised when the Company has a legal obligation to make the payment, or whenever paid, whichever is earlier.


2.


Operating profit

The operating profit is stated after charging:

2024
2023
£
£

Operating lease rentals
30,330
26,019


3.


Employees

The average monthly number of employees, including directors, during the year was 4 (2023 - 4).

Page 6

 
THE BUNGAY MEDICAL CENTRE PROPERTY COMPANY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

4.


Tangible fixed assets





Fixtures & fittings

£





At 1 April 2023
646,783


Transfers
(646,783)



At 31 March 2024

-





At 1 April 2023
510,407


Charge for the year on owned assets
19,196


Transfers
(529,603)



At 31 March 2024

-



Net book value



At 31 March 2024
-



At 31 March 2023
136,376


5.


Fixed asset investments





Listed investments

£



Valuation


At 1 April 2023
418,534


Additions
46,500


Disposals
(257,661)


Revaluations
14,309


Transfers
(221,682)



At 31 March 2024
-




Page 7

 
THE BUNGAY MEDICAL CENTRE PROPERTY COMPANY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

6.


Investment property


Long term leasehold investment property

£





At 1 April 2023
2,160,000


Transfers
(2,160,000)



At 31 March 2024
-


Comprising


Cost
775,271

Annual revaluation surplus/(deficit):


2002-2024
1,384,729

Transfers
(2,160,000)

The  valuations were made by Durrants, on an open market value for existing use basis.




Page 8

 
THE BUNGAY MEDICAL CENTRE PROPERTY COMPANY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

7.


Debtors

2024
2023
£
£


Amounts owed by group undertakings
1
4,670

Other debtors
-
170

Prepayments and accrued income
-
4,154

1
8,994



8.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
-
49,275

-
49,275



9.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
-
2,280

Other taxation and social security
-
8,051

Accruals and deferred income
-
23,208

-
33,539



10.


Deferred taxation




2024
2023


£

£






At beginning of year
(41,209)
(55,674)


Charged to the profit or loss
41,209
14,465



At end of year
-
(41,209)

Page 9

 
THE BUNGAY MEDICAL CENTRE PROPERTY COMPANY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
 
10.Deferred taxation (continued)

The deferred taxation balance is made up as follows:

2024
2023
£
£


Accelerated capital allowances
-
(41,209)

-
(41,209)


11.


Share capital

2024
2023
£
£
Authorised, allotted, called up and fully paid



1 (2023 - 20,000) ordinary share of £1.00
1
20,000

To facilitate the merger described in note 1.2, on 19 December 2023 the Company reduced and cancelled 19,999 £1 ordinary shares, and the amount by which the share capital was reduced was transferred to the profit and loss account. 



12.


Commitments under operating leases

At 31 March 2024 the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2024
2023
£
£


Later than 5 years
-
112,749

-
112,749


13.


Related party transactions

During the year the Company paid rent totalling £30,330 (2023: £26,019) to Bungay Medical Centre Charitable Trust / Scott Charity, the controlling party. The company also made payments on behalf of Bungay Medical Centre Charitable Trust / Scott Charity totalling £10,367 for the purchase of equipment for the Bungay Medical Practice. The balance outstanding owed by related parties at 31 March 2024 was £1 (2023: £4,840). 

 
Page 10